NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Galatea Bio Inc.

Galatea Bio Inc.

Private
Miami, FloridaHealthcare & Life Scienceshttps://galatea.bio/

Last Round

Series A

Mar 27, 2025

Total Funding Raised

$25M

Company Overview

Galatea Bio Inc. is a biotechnology company that advances precision medicine by using AI-driven data analytics and genomic research to improve diagnostic testing and accelerate drug discovery for diverse, underrepresented patient populations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision medicinegenomic sequencingpolygenic risk scorePRSbiobankingmolecular diagnosticsgenomic diversityclinical genetic testingpharmacogenomicsbioinformaticsbiomarker discoveryhealth equity techgenomic data repositoryclinical AIhealth equity AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galatea Bio Inc. Comparables

Compare Galatea Bio Inc. with similar companies based on industry and business-model similarity.

Galatea Bio Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Allelica, Inc.
80%
Dante Labs
76%
Genomics
76%

Galatea Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 27, 2025

Key People

Founding team and executive leadership

Carlos D. Bustamante

Chief Executive Officer

Executive Team

Francisco M. De La Vega

Chief Technology Officer

Executive Team

Galatea Bio Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 23, 2025

    Developing genetic disease risk assays with Fabric Genomics.

  • Jun 23, 2025

    Partnered with Fabric Genomics to co-develop genetic disease risk assays.

Galatea Bio Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Galatea Bio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Galatea Bio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range30
Year Founded2021
Last FundingMar 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.